A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping
Sep 1, 2007
Aneurysmal subarachnoid hemorrhage has been designated as an orphan disease and remains an important cause of morbidity and mortality despite advances in medical and surgical therapy. One important complication of subarachnoid hemorrhage is cerebral...
Clinical Studies -
Sep 1, 2007 - Mar 31, 2010
Automatically Closed
Project leader: Seule Martin, Hildebrandt Gerhard
Members: Gautschi Oliver
more
